Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2024; 581DOI:10.1016/j.mce.2023.112113. PMID:37989409. IF:3.600(Q2/4D).

Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Giménez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mir, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. DIABETES CARE. 2024; 47(2)DOI:10.2337/dc23-1355. PMID:37948469. IF:16.600(Q1/1D).

Villanueva, C, Sapena, V, Lo, GH, Seo, YS, Shah, HA, Singh, V, Tripathi, D, Schepke, M, Gheorghe, C, Bonilha, DQ, Jutabha, R, Wang, HM, Rodrigues, SG, Brujats, A, Lee, HA, Azam, Z, Kumar, P, Hayes, PC, Sauerbruch, T, Chen, WC, Iacob, S, Libera, ED, Jensen, DM, Alvarado, E, Torres, F, Bosch, J. Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 59(3)DOI:10.1111/apt.17824. PMID:38108646. IF:6.700(Q1/1D).

Torné-Ruiz, A, Reguant, M, Sanromà-Ortiz, M, Piriz, M, Roca, J, García-Expósito, J. Assessment, Treatment, and Follow-Up of Phlebitis Related to Peripheral Venous Catheterisation: A Delphi Study in Spain. Healthcare. 2024; 12(3)DOI:10.3390/healthcare12030378. PMID:38338263. IF:2.700(Q2/4D).